Treat larger, deeper structures and provide faster pain relief with real time dosing feedback. Ideal for: The busiest practices treating the most challenging cases.Models: 40W XLi, 25W XPi The LightForce® Empower IQ™ Delivery System is changing the game in laser therapy emission. Designed to be user friendly and responsive, Empower IQ™ is the new generation of delivery technology.INFLUENCE® TECHNOLOGY Influence® Technology takes into account the patient’s unique absorption characteristics and specific clinical condition to help provide the most effective treatment. Patient specifications such as condition, body type, and skin type are taken into account. The in-depth protocol settings provide recommended parameters on treatment heads and power levels to aid in clinician confidence and reduced learning time. Faster Treatments Deeper Structures Larger AreasThe 40W LightForce® XLi is our most powerful laser ever. The increased power directly impacts the time needed to apply a therapeutic dose of light energy, allowing clinicians to decrease the time required to treat effectively. The higher power equips clinicians to treat deeper and faster while covering more tissue area with the new XL Treatment Cone. Smart HandpieceBuilt-in dosing feedback technology with embedded finger switch and indicator lights. In order to achieve effective treatments and improve dosing accuracy, the Smart Handpiece assesses the operator’s speed and gives real-time visual and sensory feedback. The Smart Handpiece is ergonomically styled for operator comfort. Time with PatientsWith an average treatment time of 4-7 minutes, clinicians can use laser therapy as part of an overall plan of care and maximize the time available to treat IndicationsDeep Tissue Laser Therapy™ is used to treat painful muscles and joints associated with acute and chronic soft tissue injuries. It is also indicated for helping relieve pain and stiffness associated with osteoarthritis via its ability to increase localized blood flow. These factors make therapeutic laser a sensible modality choice for post-activity recovery.
